Skip to search formSkip to main contentSkip to account menu

Cisplatin

Known as: Cisplatina, Cysplatyna, Cis-platinum II Diamine Dichloride 
An alkylating-like inorganic platinum agent (cis-diamminedichloroplatinum) with antineoplastic activity. Cisplatin forms highly reactive, charged… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
Platinum-based drugs, and in particular cis-diamminedichloroplatinum(II) (best known as cisplatin), are employed for the… 
Highly Cited
2010
Highly Cited
2010
BACKGROUND There is no established standard chemotherapy for patients with locally advanced or metastatic biliary tract cancer… 
Review
2010
Review
2010
Cisplatin is a widely used and highly effective cancer chemotherapeutic agent. One of the limiting side effects of cisplatin use… 
Highly Cited
2008
Highly Cited
2008
PURPOSE Cisplatin plus gemcitabine is a standard regimen for first-line treatment of advanced non-small-cell lung cancer (NSCLC… 
Review
2008
Review
2008
Cisplatin is one of the most widely used and most potent chemotherapy drugs. However, side effects in normal tissues and organs… 
Highly Cited
2006
Highly Cited
2006
BACKGROUND Standard chemotherapy for newly diagnosed ovarian cancer is a platinum-taxane combination. The Gynecologic Oncology… 
Highly Cited
2003
Highly Cited
2003
PURPOSE Patients with malignant pleural mesothelioma, a rapidly progressing malignancy with a median survival time of 6 to 9… 
Review
2003
Review
2003
Cisplatin is one of the most potent antitumor agents known, displaying clinical activity against a wide variety of solid tumors…